Home
Arch Venture Fund XII reported a 20.7% stake in Neumora Therapeutics NMRA · 33,958,967 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 20.7%
- Last report
- No earlier report
- Shares held
- 33,958,967 sh
- Class
- Common Stock, $0.0001 par value
- Holder
- Arch Venture Fund XII
- Event date
- 25/10/27
- Filed
- 25/10/29
20.7% stake
Neumora Therapeutics trades, last 26 weeks
What else happened in Neumora Therapeutics around then
Filed or reported within 30 days of the trade day · 25/09/27~25/11/26Arch Venture Fund XII's other 5% stake reports
- Arch Venture Fund XII
5% stakeParabilis Medicines
5% stakeParabilis Medicines
PBLS
5.3% stake
6,412,780 sh
5.3% stake
Filed 08/14
- Arch Venture Fund XII
5% stakeSeaport Therapeutics
5% stakeSeaport Therapeutics
SPTX
11.9% stake
6,294,951 sh
11.9% stake
Filed 05/06
- Arch Venture Fund XII
5% stakeNeumora Therapeutics
5% stakeNeumora Therapeutics
NMRA
18.7% stake
33,965,419 sh
18.7% stake
Filed 04/01
- Arch Venture Fund XII
5% stakePrime Medicine
5% stakePrime Medicine
PRME
10.4% stake
18,587,036 sh
10.4% stake
Filed 25/08/11
